Qiagen Receives FDA Approval to Expand Use of EGFR Test in Lung Cancer
FDA approval allows use of the Therascreen EGFR RGQ PCR kit as a companion diagnostic for Pfizer’s Vizimpro (dacomitinib) in patients with non-small cell lung cancer.
Read MorePosted by Melissa Mayer | Oct 15, 2018 | Lung Cancer |
FDA approval allows use of the Therascreen EGFR RGQ PCR kit as a companion diagnostic for Pfizer’s Vizimpro (dacomitinib) in patients with non-small cell lung cancer.
Read MorePosted by Melissa Mayer | Oct 15, 2018 | Research |
New biomarkers detected in a 1,100-subject study accurately identify specific subtypes of ASD related to abnormalities in metabolizing certain amino acids important to typical neurodevelopment.
Read MorePosted by Melissa Mayer | Oct 15, 2018 | Lung Cancer, Melanoma, Software |
The panel accurately and sensitively detects more than 1,600 variants of clinical significance.
Read MorePosted by Melissa Mayer | Oct 14, 2018 | Research |
Peer-reviewed research using PGDx software demonstrates the importance of high-quality somatic mutation detection in clinical next-generation sequencing.
Read MorePosted by Steve Halasey | Oct 9, 2018 | Research |
Report recommends gene inclusions for high-throughput pan-myeloid NGS tests to standardize clinical practice and improve patient care.
Read More